1. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020 Subject(s): Government RegulationMedicaid -- economicsNaloxone -- supply & distributionOpioid-Related Disorders -- economicsUnited StatesUnited States. Department of Health and Human Services
